<http://schema.org/description>
"A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes. Researchers from the University of Pittsburgh School of Medicine, the Pitt Graduate School of Public Health, and Western Psychiatric Institute and Clinic of UPMC note that policymakers and insurers should consider generic-only coverage, rather than no gap coverage, to both conserve health care resources and improve health."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2013-02-cost-effectiveness-medicare-drug-schizophrenia-bipolar.html>